Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies. [electronic resource]
Producer: 20210203Description: 866-876 p. digitalISSN:- 1552-4833
- Biomarkers, Tumor -- antagonists & inhibitors
- Costello Syndrome -- genetics
- Ectodermal Dysplasia -- genetics
- Facies
- Failure to Thrive -- genetics
- Heart Defects, Congenital -- genetics
- Humans
- Intersectoral Collaboration
- Molecular Targeted Therapy
- Mutation
- National Cancer Institute (U.S.)
- Neurofibromatosis 1 -- genetics
- Noonan Syndrome -- genetics
- Research Report
- Signal Transduction
- United States
- ras Proteins -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.